[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001295450A1 - Method of polypeptide renaturation - Google Patents

Method of polypeptide renaturation

Info

Publication number
AU2001295450A1
AU2001295450A1 AU2001295450A AU9545001A AU2001295450A1 AU 2001295450 A1 AU2001295450 A1 AU 2001295450A1 AU 2001295450 A AU2001295450 A AU 2001295450A AU 9545001 A AU9545001 A AU 9545001A AU 2001295450 A1 AU2001295450 A1 AU 2001295450A1
Authority
AU
Australia
Prior art keywords
renaturation
polypeptide
polypeptide renaturation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295450A
Inventor
Chetan Chitnis
Kailash Pandey
Priyabrata Pattnaik
Sanjay Singh
Syed Shams YAZDANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Centre for Genetic Engineering and Biotechnology
Original Assignee
ICGEB
International Centre for Genetic Engineering and Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICGEB, International Centre for Genetic Engineering and Biotechnology filed Critical ICGEB
Publication of AU2001295450A1 publication Critical patent/AU2001295450A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001295450A 2000-08-07 2001-08-03 Method of polypeptide renaturation Abandoned AU2001295450A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0019375 2000-08-07
GBGB0019375.5A GB0019375D0 (en) 2000-08-07 2000-08-07 Method of polypeptide renaturation
PCT/EP2001/009023 WO2002012292A2 (en) 2000-08-07 2001-08-03 Method of polypeptide renaturation

Publications (1)

Publication Number Publication Date
AU2001295450A1 true AU2001295450A1 (en) 2002-02-18

Family

ID=9897148

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295450A Abandoned AU2001295450A1 (en) 2000-08-07 2001-08-03 Method of polypeptide renaturation

Country Status (3)

Country Link
AU (1) AU2001295450A1 (en)
GB (1) GB0019375D0 (en)
WO (1) WO2002012292A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703386D0 (en) * 1997-09-19 1997-09-19 Karolinska Innovations Ab Malaria polypeptides
DE102004041639A1 (en) * 2004-08-27 2006-03-02 Bioceuticals Arzneimittel Ag Method for obtaining biologically active human G-CSF from inclusion bodies
CN100457780C (en) * 2005-06-29 2009-02-04 中国人民解放军第二军医大学 Recombinant Plasmodium falciparum 175kD erythrocyte conjugated antigen functional region protein and its prepn and use
TWI457133B (en) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa Novel composition
ES2609418T3 (en) 2007-03-02 2017-04-20 Glaxosmithkline Biologicals Sa Novel procedure and compositions
US9717788B2 (en) 2007-03-02 2017-08-01 Glaxosmithkline Biologicals Sa Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant
GB0815872D0 (en) 2008-09-01 2008-10-08 Pasteur Institut Novel method and compositions
EP2440574B1 (en) * 2009-06-09 2021-05-26 Bharat Biotech International Limited Stable immunogenic protein having multiple cysteines molecules process therefor and composition thereof
GB201022007D0 (en) 2010-12-24 2011-02-02 Imp Innovations Ltd DNA-sensor
GB201116248D0 (en) 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
WO2013108272A2 (en) * 2012-01-20 2013-07-25 International Centre For Genetic Engineering And Biotechnology Blood stage malaria vaccine
US20180311340A1 (en) 2015-10-19 2018-11-01 Cadila Healthcare Limited New adjuvant and vaccine composition containing the same
US10695424B2 (en) 2016-12-07 2020-06-30 Glaxosmithkline Biologicals S.A. Method of making a liposome composition

Also Published As

Publication number Publication date
WO2002012292A3 (en) 2002-05-16
WO2002012292A2 (en) 2002-02-14
GB0019375D0 (en) 2000-09-27

Similar Documents

Publication Publication Date Title
AU2001280201A1 (en) Methods of synthesizing cell-free protein
AU2002362197A1 (en) Method of stabilizing protein
AU2001294175A1 (en) Method of purifying antibody
AUPR208000A0 (en) Method of document searching
AU2001241075A1 (en) Method of anticipating interaction between proteins
AU4107501A (en) Method of anticipating interaction between proteins
AU2001295450A1 (en) Method of polypeptide renaturation
AU2001278739A1 (en) Method of modifying microorganism-origin transglutaminase
AU2002214286A1 (en) Method of profiling protein
AU2001284418A1 (en) Novel polypeptide
AU2001294258A1 (en) Method of purifying plavastatin
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2002361763A1 (en) Method of reducing angiogenesis
AU2001295915A1 (en) Method of forming polypeptide particles
AU2002354363A1 (en) Method of activating protein
AU2002213954A1 (en) Method for the selective modification of peptides and proteins
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001261343A1 (en) Method of regulating angiogenesis using ryk protein
AU2001277750A1 (en) Use of polypeptide
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2001253092A1 (en) Method for detection of truncated proteins
AU2002353431A1 (en) Method of modification of a protein or polypeptide
AU2001286268A1 (en) Method of forming complex
AU2002215721A1 (en) Method of cloning animals